Gts Securities LLC Exact Sciences Corp Put Options Transaction History

Gts Securities LLC

  • $46.5 Billion
  • Q2 2024

Put Options

4 transactions
Quarter Operation Price Per put puts change puts Held SEC Form
Q2 2024

Aug 14, 2024
SELL
$41.33 - $74.26 $1.55 Million - $2.78 Million
-37,500 Reduced 47.65%
41,200 $1.74 Million
Q1 2024

May 15, 2024
BUY
$56.27 - $73.77 $163,183 - $213,933
2,900 Added 3.83%
78,700 $5.44 Million
Q4 2023

Feb 14, 2024
BUY
$59.06 - $75.72 $608,318 - $779,916
10,300 Added 15.73%
75,800 $5.61 Million
Q3 2023

Nov 15, 2023
BUY
$65.94 - $99.04 $4.32 Million - $6.49 Million
65,500 New
65,500 $4.47 Million

Others Institutions Holding EXAS

# of Institutions
610
Shares Held
166M
Call Options Held
1.93M
Put Options Held
1.23M
View Full List

About EXACT SCIENCES CORP

EXAS Quotes by TradingView
  • Ticker EXAS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 176,960,000
  • Market Cap $12B
  • Description
  • Exact Sciences Corporation provides cancer screening and diagnostic test products in the United States and internationally. The company offers Cologuard, a non-invasive stool-based DNA screening test to detect DNA and hemoglobin biomarkers associated with colorectal cancer and pre-cancer. It also provides Oncotype DX, a gene expression tests for...
More about EXAS
Track This Portfolio

Track Gts Securities LLC Portfolio

Follow Gts Securities LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Gts Securities LLC, based on Form 13F filings with the SEC.

News

Stay updated on Gts Securities LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email